On the recordJanuary 31, 2012
When we examine claims as serious as these, we must insist on data and on facts.
Source
congress.govEditor's note · Context
Stresses the need for data and facts over anecdotes in discussions about FDA regulations.
Share
More from Henry Waxman
Jul 11, 2019
The House's need for all the facts surrounding suspected Presidential offences cannot of course be circumscribed by an executive determination of what is relevant.
Nov 20, 2014
The reason I qualified it is because I see no reason to oppose the amendment. It is not objectionable. But it doesn't actually fix the bill's four problems. Subsection 3(b) of the bill gives new sources amnesty from compliance with a new…
Dec 2, 2014
We need to make sure that companies and regulators can keep pace with innovation.
Other voices in this conversation
